Search Result for "head and neck"
Clinical Trial

A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications

To assess the efficacy of ABBV-400 in each solid tumor indication, including advanced or metastatic hepatocellular (HCC), biliary tract cancer (BTC), pancreatic ductal adenocarcinoma (PDAC), esophageal squamous cell carcinoma (ESCC), triple negative (TN) breast cancer (BC), hormone receptor-positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) BC, and head and neck squamous cell carcinoma (HNSCC). The purpose of this study is to evaluate ABBV-400 in subjects with select solid tumors. This study will consist of multiple cohorts with each cohort investigating ABBV-400 at 3 mg/kg Q3W.

Cancer Treatment
Speech and Swallow Therapy During Cancer Treatment

Head and neck cancer treatment can affect your ability to speak or swallow. Experts at Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, help you move forward with specialized therapies. Whether you experience speech or swallowing changes during treatment or years later, we are here for you.

Cancer Treatment
Robotic Surgery

At Mays Cancer Center, home to UT Health San Antonio MD Anderson, our surgical experts have extensive experience with advanced robotic techniques. Robotic surgery helps us safely remove complex cancers while protecting nearby healthy tissues. It provides a high level of precision for delicate regions such as the prostate, genitourinary tract, and head and neck. With robotic techniques, many people experience a faster recovery.